medcura
Riverdale, US · Delaware corporation · 4 known investors
Medcura develops hemostasis (bleeding management) products, working with surgeons and healthcare professionals to deliver bleeding-control solutions. The company operates in the medical device industry, targeting surgical and clinical care settings.
Founders & leadership
JB.avif)
Jim BuckPresident, CEO & Director
MD
Matthew Dowling, Ph.DDr. Dowling is the Chief Scientic Officer of the Issuer.
RV
Rich VincentMr. Vincent is the Chief Financial Officer of the Issuer.
LT
Larry TiffanyMr. Tiffany is the Executive Chairman of the Issuer.
PT
Peter ThomasExecutive
MD
Matthew DowlingNamed on SEC filing
Board
AA
Abbas Ardehali, M.D.Board director
Investors · 4
Competitors · 5
by search overlapDoximity43 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Walgreens32 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Chewy27 shared keywordsChewy is an online retailer for pet products and prescription medications, offering an Autoship subscription service and a pharmacy where licensed pharmacists coordinate with veterinarians to fill pet prescriptions. It serves pet owners with home delivery of pet supplies and medications.
Practo26 shared keywordsPracto is a healthcare platform offering online video consultations with verified doctors across specialties and appointment booking for in-clinic visits. It serves patients in India, connecting them with doctors across areas such as dentistry, gynecology, pediatrics, and general medicine.
Anacor24 shared keywordsPfizer is a pharmaceutical company that researches, develops, and manufactures medicines and treatments across a range of diseases. It also runs patient assistance programs and global health initiatives to broaden access to its products.
Companies competing with medcura for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$60.2M disclosed across 7 rounds · 2016–2025
▶$28.5MraisedJul 2025 · 174 investors · BiotechnologyRule 506(b)
▶$28.5MraisedJul 2025 · 174 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rich VincentExecutive Officer
- Jim BuckDirector, Executive Officer
- Larry TiffanyDirector, Executive Officer
- Abbas Ardehali, M.D.Director
- Matthew Dowling, Ph.DDirector, Executive Officer
- Offering amount
- $38.3M
- Amount sold
- $28.5M
- Finders' fees
- $52.2K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.5MraisedJul 2024 · 151 investors · BiotechnologyRule 506(b)
▶$22.5MraisedJul 2024 · 151 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Abbas Ardehali, M.D.Director
- Matthew Dowling, Ph.DDirector, Executive Officer
- Jim BuckDirector, Executive Officer
- Rich VincentExecutive Officer
- Larry TiffanyDirector, Executive Officer
- Offering amount
- $22.8M
- Amount sold
- $22.5M
- Sales commissions
- $119K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedNov 2021 · 45 investors · BiotechnologyRule 506(b)
▶$3.5MraisedNov 2021 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim BuckDirector
- Rich VincentExecutive Officer
- Matthew DowlingExecutive Officer, Director
- Larry TiffanyExecutive Officer, Director
- Offering amount
- $5.8M
- Amount sold
- $3.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedSep 2020 · 55 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2020 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew DowlingExecutive Officer, Director
- Alex ArrowDirector
- Larry TiffanyExecutive Officer, Director
- Jim BuckDirector
- Rich VincentExecutive Officer
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2018 · 36 investors · BiotechnologyRule 506(b)
▶$1.6MraisedJul 2018 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew DowlingExecutive Officer, Director
- Alex ArrowDirector
- Jim BuckDirector
- Larry TiffanyExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedNov 2016 · 14 investors · BiotechnologyRule 506(b)
▶$1.1MraisedNov 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry TiffanyDirector
- Alex ArrowDirector
- Matthew DowlingExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $1.1M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11raisedApr 2016 · 1 investors · BiotechnologyRule 506(b)
▶$11raisedApr 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry TiffanyDirector
- Peter ThomasExecutive Officer, Director
- Matthew DowlingExecutive Officer, Director
- Offering amount
- $200
- Amount sold
- $11
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does medcura do?
- Medcura develops hemostasis (bleeding management) products, working with surgeons and healthcare professionals to deliver bleeding-control solutions. The company operates in the medical device industry, targeting surgical and clinical care settings.
- Who are medcura's investors?
- medcura's investors include Aspira Capital, Maryland TEDCO, Robin Hood Ventures, TEDCO.
- How much funding has medcura raised?
- medcura has disclosed $60.2M raised across 7 rounds.
- Where is medcura headquartered?
- medcura is headquartered in Riverdale, US.